Literature DB >> 14601053

Intensified oxidative and nitrosative stress following combined ALA-based photodynamic therapy and local hyperthermia in rat tumors.

Juergen Frank1, Christine Lambert, Hans Konrad Biesalski, Oliver Thews, Peter Vaupel, Debra K Kelleher.   

Abstract

Oxidative stress-related changes in tumors upon localized hyperthermia (HT), 5-aminolevulinic acid-based photodynamic therapy (ALA-PDT) and their combination (ALA+HT) were examined after the observation that the antitumor effects of ALA-PDT could be significantly enhanced upon simultaneous application of HT. Rats bearing s.c. DS-sarcomas (0.6-1.0 ml) on the hind foot dorsum were anesthetized and underwent one of the following treatments: (i) ALA-PDT (375 mg/kg 5-ALA i.v.); (ii) localized HT, 43 degrees C for 60 min; (iii) combined ALA-PDT and HT [=ALA+HT]. Appropriate control experiments were also performed. After treatment, tumors were excised and rapidly frozen for later analysis of nitrosative stress (protein nitration), apoptotic events (TUNEL, caspase activation, DNA and RNA fragmentation), expression of heat shock proteins (hsp70 and HO-1), glutathione (GSH) levels and glutathione peroxidase (GPx) activity. Protein nitration was found to increase upon treatment, being especially pronounced in the ALA+HT group, and could partially be related to areas surrounding microvessels. The extent of nitrosative stress also correlated well with the appearance of the markers of apoptosis and the inhibition of in vivo tumor growth as seen in a previous study. GSH levels decreased upon treatment, the reduction being most prominent in the ALA-PDT and ALA+HT groups. GPx activity, however, showed a significant decrease only in the ALA-PDT group. Whereas hsp70 expression increased upon HT, ALA-PDT caused a decrease, and these opposing effects were nullified with ALA+HT. The results obtained point to a number of cellular mechanisms-including effects on cellular defense mechanisms and an abrogation of the heat shock defense mechanism-that may interact to achieve the potentiated tumor response rate seen in vivo upon combined treatment. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14601053     DOI: 10.1002/ijc.11507

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Light-Activated Pharmaceuticals: Mechanisms and Detection.

Authors:  David Kessel; John Reiners
Journal:  Isr J Chem       Date:  2012-09-01       Impact factor: 3.333

2.  Iron Oxide Nanoflowers @ CuS Hybrids for Cancer Tri-Therapy: Interplay of Photothermal Therapy, Magnetic Hyperthermia and Photodynamic Therapy.

Authors:  Alberto Curcio; Amanda K A Silva; Sonia Cabana; Ana Espinosa; Benoit Baptiste; Nicolas Menguy; Claire Wilhelm; Ali Abou-Hassan
Journal:  Theranostics       Date:  2019-02-12       Impact factor: 11.556

Review 3.  Hyperthermia Treatment as a Promising Anti-Cancer Strategy: Therapeutic Targets, Perspective Mechanisms and Synergistic Combinations in Experimental Approaches.

Authors:  Ga Yeong Yi; Min Ju Kim; Hyo In Kim; Jinbong Park; Seung Ho Baek
Journal:  Antioxidants (Basel)       Date:  2022-03-24

4.  Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells.

Authors:  Ruud Weijer; Mans Broekgaarden; Rowan F van Golen; Esther Bulle; Esther Nieuwenhuis; Aldo Jongejan; Perry D Moerland; Antoine H C van Kampen; Thomas M van Gulik; Michal Heger
Journal:  BMC Cancer       Date:  2015-12-26       Impact factor: 4.430

5.  Fetal liver mesenchymal stem cells restore ovarian function in premature ovarian insufficiency by targeting MT1.

Authors:  Boxian Huang; Chunfeng Qian; Chenyue Ding; Qingxia Meng; Qinyan Zou; Hong Li
Journal:  Stem Cell Res Ther       Date:  2019-11-29       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.